150 related articles for article (PubMed ID: 3383207)
1. Autologous antibodies to human bladder cancer.
Grossman HB; Wedemeyer G; Stein J
Cancer Immunol Immunother; 1988; 26(3):269-72. PubMed ID: 3383207
[TBL] [Abstract][Full Text] [Related]
2. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
Schneider MU; Troye M; Paulie S; Perlmann P
Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity.
Lee VK; Harriott TG; Kuchroo VK; Halliday WJ; Hellström I; Hellström KE
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6286-90. PubMed ID: 3875859
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcal protein A assay for detection of antibody directed at renal cancer cells.
Leblanc PA; Taffet SM; Fried FA; Avis FP
J Urol; 1979 Jun; 121(6):724-7. PubMed ID: 458941
[TBL] [Abstract][Full Text] [Related]
5. Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
Ben-Aissa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Lundblad ML; Gustafson H; Jonsdottir I; Perlmann P
Br J Cancer; 1985 Jul; 52(1):65-72. PubMed ID: 4015953
[TBL] [Abstract][Full Text] [Related]
6. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
[TBL] [Abstract][Full Text] [Related]
7. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
Pizza G; De Vinci C
J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
[No Abstract] [Full Text] [Related]
8. Plasma membrane-associated antigens on tumor cells derived from transitional-cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens.
Schneider MU; Paulie S; Troye M; Perlmann P
Int J Cancer; 1980 Aug; 26(2):193-202. PubMed ID: 7203713
[TBL] [Abstract][Full Text] [Related]
9. Production and characterization of monoclonal antibodies to the established human bladder cancer cell lines.
Sasaki M
Keio J Med; 1984 Apr; 33(1):39-56. PubMed ID: 6384610
[No Abstract] [Full Text] [Related]
10. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. II. Identification of the cellular target structures by immunoprecipitation and SDS-PAGE analysis.
Paulie S; Koho H; Ben-Aissa H; Hansson Y; Lundblad ML; Perlmann P
Cancer Immunol Immunother; 1984; 17(3):173-9. PubMed ID: 6383601
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence.
Koho H; Paulie S; Ben-Aissa H; Jónsdóttir I; Hansson Y; Lundblad ML; Perlmann P
Cancer Immunol Immunother; 1984; 17(3):165-72. PubMed ID: 6383600
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures.
Troye M; Vilien M; Pape GR; Perlmann P
Int J Cancer; 1980 Jan; 25(1):33-43. PubMed ID: 7399743
[TBL] [Abstract][Full Text] [Related]
13. Production of antibodies to cellular antigens by EBV-transformed lymphocytes from patients with urinary bladder carcinoma.
Paulie S; Lundblad ML; Hansson Y; Koho H; Ben-Aissa H; Perlmann P
Scand J Immunol; 1984 Nov; 20(5):461-70. PubMed ID: 6095441
[TBL] [Abstract][Full Text] [Related]
14. [The study of mouse monoclonal antibody to human transitional cell carcinoma of the bladder].
Takahashi S; Takahashi N; Takahashi K; Koizumi Y; Kawaguchi T; Togashi S; Suzuki T; Funyu T
Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):791-801. PubMed ID: 3694976
[No Abstract] [Full Text] [Related]
15. In vitro cytotoxicity studies in bladder and renal cell cancer.
Elhilali MM; Nayak SK
Urology; 1976 May; 7(5):488-91. PubMed ID: 1274005
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.
Kingsley EA; Carter TE; Barrow KD; Russell PJ
Cancer Immunol Immunother; 1995 Dec; 41(6):348-54. PubMed ID: 8635192
[TBL] [Abstract][Full Text] [Related]
17. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum.
Bloom ET
Natl Cancer Inst Monogr; 1978 Dec; (49):57-8. PubMed ID: 86168
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to two mouse bladder carcinoma antigens.
Hellström I; Rollins N; Settle S; Chapman P; Chapman WH; Hellström KE
Int J Cancer; 1982 Feb; 29(2):175-80. PubMed ID: 7037659
[TBL] [Abstract][Full Text] [Related]
19. [Reactivity of anti-human bladder cancer monoclonal antibodies with bladder tumor tissues].
Kagawa S; Takigawa H; Kurokawa K; Masuko T; Hashimoto Y
Nihon Hinyokika Gakkai Zasshi; 1986 Jan; 77(1):133-9. PubMed ID: 3723905
[No Abstract] [Full Text] [Related]
20. Incidence of serum antibody reactivity to autologous head and neck cancer cell lines and augmentation of antibody reactivity following acid dissociation and ultrafiltration.
Vlock DR; Scalise D; Schwartz DR; Richter DE; Krause CJ; Baker SR; Carey TE
Cancer Res; 1989 Mar; 49(6):1361-5. PubMed ID: 2924293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
